Picture of Phathom Pharmaceuticals logo

PHAT — Phathom Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Phathom Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

* Phathom Pharmaceuticals Inc  PHAT.OQ  reported a quarterly
adjusted loss of $1.56​​ per share for the quarter ended in
June, lower than the same quarter last year, when the company
reported EPS of -84 cents.  The mean expectation of
seven analysts for the quarter was for a loss of $1.38 per
share. Wall Street expected results to range from $-1.65
to $-1.28 per share.
    * Revenue was $7.32 million​; analysts expected $5.81
million. 
    * Phathom Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of $1.56​.
    * The company reported a quarterly loss of $91.45 million.
    * Phathom Pharmaceuticals Inc shares had risen by 5.0% this
quarter and gained 18.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 7.4%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Phathom
Pharmaceuticals Inc is $24.00 
This summary was machine generated from LSEG data August 8 at
02:40 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -1.38          -1.56          Missed
 Mar. 31 2024      -1.31          -1.42          Missed
 Dec. 31 2023      -1.08          -1.39          Missed
 Sep. 30 2023      -0.89          -0.76          Beat

Recent news on Phathom Pharmaceuticals

See all news